InvestorsHub Logo
Followers 13
Posts 1550
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Thursday, 12/03/2020 3:38:07 PM

Thursday, December 03, 2020 3:38:07 PM

Post# of 34635
A lot on the subject of blame, and wasted opportunities, and wasted cash.

Listen, it all sucked since we were at $7 and hoping it went to $10.
Covid hurt MRKR and most other biotechs and their trials, but the blame would go to China or wet markets or the lab that created it or etc.

The reagent fiasco, Peter or SOMEBODY should have MADE SURE the company that was supplying the reagent had the PROPER PAPERWORK. That WAS wasted time and money for no reason.

The TPIV efforts that didn't work out wasn't an intentional waste of time/money. It was just what small biotechs do. They go with their idea, spend time and money on it, and then it either does or does not work out.
In hindsight, maybe should have been ditched earlier to focus on AML and Pancreatic.

The only thing we can expect is basically nothing happening until we get good data from a trial or until they tell us EXACTLY what the new facility is for and WHEN will it start to produce revenue.

I still own my stupid amount of shares and already lost every penny in MRKR call options, but no one held a gun to my head and made me buy any of it, so I guess part of the BLAME is mine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News